Trials / Withdrawn
WithdrawnNCT05041114
SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis
Stentrode With Thought-controlled Digital Switch: An Early Feasibility Study of the Safety of an Endovascular Motor Neuroprosthesis in Participants With Severe Upper Limb Impairment.
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Synchron Medical, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The Synchron Motor Neuroprosthesis (MNP) is intended to be used in subjects with severe motor impairment, unresponsive to medical or rehabilitative therapy and a persistent functioning motor cortex. The purpose of this research is to evaluate safety and feasibility. The MNP is a type of implantable brain computer interface which bypasses dysfunctional motor neurons. The device is designed to restore the transmission of neural signal from the cerebral cortex utilized for neuromuscular control of digital devices, resulting in a successful execution of non-mechanical digital commands.
Conditions
- Neurologic Disorder
- Paralysis
- Paralysis; Stroke
- Amyotrophic Lateral Sclerosis
- Muscular Dystrophies
- Spinal Cord Injury
- Stroke, Lacunar
- Stroke, Brainstem
- Upper Limb Injury
- Spinal Muscular Atrophy
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Motor Neuroprosthesis | Type of implantable brain computer interface |
Timeline
- Start date
- 2022-04-21
- Primary completion
- 2022-11-30
- Completion
- 2022-11-30
- First posted
- 2021-09-10
- Last updated
- 2023-03-21
Locations
3 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT05041114. Inclusion in this directory is not an endorsement.